| | | | | | | | | | |
|
| |
|
| Dockets Entered
On January 20, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2000P-0586
|
| Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
|
|
|
|
|
| 2004P-0464
|
| Vitamin D and Calcium and Reduced Risk of Osteoporosis
|
|
|
|
|
| 2005N-0413
|
| Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
|
|
|
|
|
| 2005N-0479
|
| International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Butorphanol; Delta-9-tetrahydrocannabinol (Dronabinol); Gamma-Hydroxybutyric Acid; Ketamine;
|
|
|
|
|
|
|
|
|
| 2005P-0459
|
| To enforce ban on carbon monoxide gas in fresh meat packaging
|
|
|
|
|
| 2006A-0041
|
| genetic toxicology testing: the Ames Assay, Mouse Lymphoma Assay and the Micronucleus Assay
|
|
|
|
|
| 2006E-0040
|
| Patent Extension Application for ROZEREM (ramelteon), U.S. Patent No. 6,034,239
|
|
|
|
|
| 2006E-0042
|
| Patent Extension Application for CUBICIN (daptomycin for injection), U.S. Patent No. 4,885,243
|
|
|
|
|
| 2006E-0043
|
| Patent Extension Application for TYGACIL (tigecycline), U.S. Patent No. 5,529,990
|
|
|
|
|
| 2000P-0586
|
| Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
|
|
|
|
|
| EC
1
|
| Mr. Don Dahlstrom
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
2
|
| Mr. Don Dahlstrom
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
3
|
| California Dairies, Inc.
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
4
|
| Kraft Foods Global
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
5
|
| Family Dairies USA
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
6
|
| International Dairy Foods Association
|
| Vol #:
|
| 28
|
|
|
|
|
| EC
7
|
| Dairy Farmers of America Inc.
|
| Vol #:
|
| 28
|
|
|
|
|
| 2004P-0464
|
| Vitamin D and Calcium and Reduced Risk of Osteoporosis
|
|
|
|
|
| LET
4
|
| The Beverage Institute for Health & Wellness
|
| Vol #:
|
| 9
|
|
|
|
|
| 2005N-0413
|
| Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
|
|
|
|
|
| C
7
|
| Center for Science in the Public Interest (CSPI), Association of American Medical Colleges, etc
|
| Vol #:
|
| 2
|
|
|
|
|
| C
8
|
| Federal Trade Commission
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
2
|
| A Strong
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
3
|
| US Canola Association
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
4
|
| Federal Trade Commission
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005N-0479
|
| International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Butorphanol; Delta-9-tetrahydrocannabinol (Dronabinol); Gamma- Hydroxybutyric Acid; Ketamine;
|
|
|
|
|
|
|
|
|
|
|
| C
6
|
| Reckitt Benckiser Pharmaceuticals Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
7
|
| NORML
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
8
|
| American Osteopathic Academy of Addiction Medicine
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
9
Attachment
|
| Jazz Pharmaceuticals
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
10
|
| Sakijo International
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
11
|
| Sakijo International
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
| |
|
| EC
12
|
| American Society of Addiction Medicine
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
13
|
| American Academy of Addiction Psychiatry
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
14
|
| PhRMA
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 15
|
| Pinney Associates
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
16
|
| Pinney Associates
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
17
|
| AMERICAN PSYCHIATRIC ASSOCIATION
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
18
|
| Nyambene Miraa Trade Association
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
2
|
| Purdue Pharma LP, Schering-Plough Corporation
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
3
|
| PriCara, a Unit of Ortho-McNeil Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0459
|
| To enforce ban on carbon monoxide gas in fresh meat packaging
|
|
|
|
|
| C
1
|
| Consumer Federation of America
|
| Vol #:
|
| 2
|
|
| |
|
| 2006A-0041
|
| genetic toxicology testing: the Ames Assay, Mouse Lymphoma Assay and the Micronucleus Assay
|
|
|
|
|
| AP
1
|
| Litron Laboratories
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006E-0040
|
| Patent Extension Application for ROZEREM (ramelteon), U.S. Patent No. 6,034,239
|
|
|
|
|
| APP 1
|
| Takeda Pharmaceuticals North America, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| LET 1
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006E-0042
|
| Patent Extension Application for CUBICIN (daptomycin for injection), U.S. Patent No. 4,885,243
|
|
|
|
|
| APP
1
|
| Cubist Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006E-0043
|
| Patent Extension Application for TYGACIL (tigecycline), U.S. Patent No. 5,529,990
|
|
|
|
|
| APP
1
|
| Wyeth Holdings Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
